GLP-1 and menopause: How Semaglutide is changing midlife weight and symptom management

July 22, 2026

GLP-1 medications like semaglutide and tirzepatide are changing how people manage weight during menopause. Here's what the research says about symptom relief, muscle preservation, and how GLP-1s work alongside hormone therapy.

Hormonal fluctuations as you age can make managing weight more difficult. GLP-1 receptor agonists are a new frontier for women seeking relief from menopause-related weight gain and “menopause belly.” There is a growing conversation online about semaglutide and menopause, and the scientific evidence fueling it. For people undergoing the menopausal transition and struggling with weight loss, GLP-1s could offer a safe, clinically-proven way to improve overall health.

Key takeaways

• The menopausal transition is a completely normal part of aging. During this time, people may notice changes in their bodies, such as weight gain, difficulty losing weight, or insulin resistance.
• GLP-1 therapy can counter menopause-related metabolic slowdown and unhealthy visceral fat gain.
• Combining semaglutide with HRT and lifestyle changes delivers greater results for people in all stages of menopause.
• Using GLP-1 for menopause treatment should always be supervised by a medical provider and individualized to the person. There is no one-size-fits-all approach to weight management during menopause.

What is GLP-1 and how does it work?

GLP-1 stands for “glucagon-like peptide-1” which is a key hormone that helps the body regulate blood sugar levels, insulin levels, and metabolism.

When someone eats, their digestive system processes carbohydrates as glucose (sugar) and moves it into the bloodstream. The GLP-1 hormone alerts the pancreas to release insulin, which helps turn glucose into energy. At the same time, GLP-1s tell the body to slow glucagon release, which raises blood sugar levels. This keeps blood sugar levels in a healthy range.

GLP-1 medications, also called GLP-1 receptor agonists (GLP-1 RAs), are used to help the brain and gut work together to control hunger and metabolism by mimicking the GLP-1 hormone. They slow down digestion and reduce hunger signals, helping people feel full sooner and stay full longer.

The use of GLP-1 medications can result in weight loss and better metabolic control. They are used to treat type 2 diabetes or obesity.

Some of the most common brand names of GLP-1 medications are:

• Ozempic
• Wegovy
• Zepbound
• Mounjaro

Compounded GLP-1 vs Ozempic

While many name-brand GLP-1s have become household names, some people may also be prescribed compounded GLP-1 medications. Compounded GLP-1s are created to mimic the original GLP-1 medications by outsourcing to pharmacies not connected to the manufacturers of those brand-name products. Unlike the brand-name products, these compounds have not been FDA-approved. The ingredients are FDA-approved, but the customized final version of the medication is not.

Why are compounded GLP-1s created? Although typically it is illegal to copy a medication when the original product is under patent, compounded medications are legally allowed during an FDA-declared drug shortage.

Risks of compounded GLP-1s include:

• Improper prescriptions
• Dosing errors
• Lack of standardization
• Contamination
• Misbranding of products

The FDA is currently concerned with an increase in cases of unapproved compounded semaglutide and tirzepatide marketed in the U.S., encouraging consumers to be cautious of where they are getting their medications from.

GLP-1 and the “Menopause Belly”

“Menopause belly” refers to the accumulation of visceral fat linked to estrogen decline during the menopausal transition. Visceral fat is normal and something everyone has, which acts as a layer of protection around the organs. Too much visceral fat can lead to a higher risk of cardiovascular disease.

GLP-1 therapy has been proven to significantly reduce visceral fat content in adults. However, studies have also found that GLP-1 therapies can result in the loss of muscle mass.

Luckily, there are ways to enhance the results of GLP-1 medication to target visceral fat and support muscle preservation.

• Pair GLP-1 with resistance training 3x weekly.
• Maintain high-protein intake to support lean muscle.
• Monitor bone health to prevent loss with rapid weight reduction.

Patients who regularly exercise and maintain a healthy diet throughout treatment and beyond have the best chance of preserving lean body mass while losing fat.

Why weight gain is common during menopause

The menopausal transition is truly a metabolic transition, as hormonal shifts trigger changes in muscle mass, how the body stores fat, and insulin resistance. A new cardiometabolic baseline is set that has an impact on long-term bone, muscle, and heart health. Midlife women gain an average of 1.5 pounds per year.

These are the primary factors of a metabolic slowdown that leads to the “menopause belly”:

• Metabolism slows with age, which results in the body burning fewer calories at rest than it did in younger age. Muscle mass also decreases with age. Together, these bodily changes, along with hormonal changes, contribute to fat gain around the midsection.
• Menopause also increases the risk of insulin resistance, which can cause blood sugar levels to rise. This may result in the body storing more fat, particularly visceral fat that surrounds internal organs, which is particularly dangerous.
• Additionally, many women experience increased stress during midlife due to changes in relationships, work, or health. Chronic stress elevates cortisol levels, which can also promote fat accumulation around the midsection.

But weight gain alone isn’t the only reason many end up searching for GLP-1 solutions for menopause belly. For many, the menopausal transition can lead to mood changes, anxiety, trouble sleeping, self-esteem issues, and disruption in quality of life. Treatments for behavioral and dietary health are known to improve the emotional well-being of people experiencing menopause, leading some experts to believe weight loss with GLP-1s could have similar benefits.

How GLP-1 medications may help menopause-related weight changes

There’s a lot of interest in using GLP-1s for menopause weight loss, but what should individuals expect once they begin treatment? The most common outcomes for GLP-1 users are:

• Reduced appetite and feeling full or satiated longer
• Improved blood sugar
• Weight loss (of 10–20% of body weight)

Let’s look at these outcomes in more detail.

Reduce “food noise” and suppress hunger cues. Hormonal fluctuations during perimenopause can make weight management particularly challenging because they can affect appetite regulation. When estrogen levels dip, appetites may rise—including cravings for carbs, sweets, and other less healthful foods that contribute to weight gain.

Improve blood sugar levels and insulin sensitivity. Midlife muscle loss can affect blood sugar regulation, which can also lead to insulin resistance. When the body doesn’t process glucose efficiently, individuals become susceptible to chronic health conditions like high blood pressure and type 2 diabetes, as well as additional weight gain.

Encourage fat loss around the midsection. Muscle loss around the middle typically results in fat replacing it. The muscle in the abdomen is a metabolically active muscle, which contributes to metabolism. So when there’s less muscle, metabolism slows. GLP-1 medications can help offset some of these changes.

The effects of midlife weight gain extend far beyond aesthetics, contributing to an increased risk of heart disease, type 2 diabetes (T2D), and other metabolic diseases. But with the help of GLP-1 medications such as tirzepatide and semaglutide, recent studies show that patients can reduce their total body weight by 10–20%.

Semaglutide and menopause symptoms beyond weight

How do GLP-1 and menopause symptoms interact? It turns out, GLP-1 therapy may play a role in broader menopause symptom relief beyond just weight management.

For instance:

• Weight gain and insulin resistance during menopause can exacerbate hot flashes. By managing weight fluctuations and glucose levels, patients may experience less intense hot flashes.
• Some studies indicate that GLP-1s improve mood and mental health, while others suggest an elevated risk of depression and anxiety.
• More stable glucose levels can improve fatigue and concentration.
• Although weight loss can contribute to reduced bone strength, the addition of exercise to a person’s routine can help offset bone loss.

Combining GLP-1 therapy with hormone replacement therapy (HRT)

Can GLP-1 therapy be combined with hormone replacement therapy (HRT)? Yes! In fact, a new study led by Mayo Clinic found that women who used HRT for menopause, along with tirzepatide, lost around 35% more weight than those taking tirzepatide alone. Additionally, a 2024 study found that for postmenopausal women with overweight or obesity treated with semaglutide, hormone therapy led to improved weight loss.

HRT and GLP-1 therapies complement each other for other outcomes, too. For example, people in menopause experience a drop in estrogen levels, which leads to bone density loss. Losing weight can also contribute to weakened bones. But hormone therapy has been found to reduce osteoporosis risk in some patients. Furthermore, supplementing lower estrogen levels helps protect muscles, joints, and ligaments, which in turn helps protect bones.

For those going through the menopausal transition, hormonal health and weight management often go hand-in-hand. Finding the right balance of treatment through GLP-1s and HRT can improve metabolic resilience and enhance overall quality of life. For the 20% of the workforce in some phase of the menopause transition, holistic support, such as Carrot’s hormonal healthcare journey, can provide much-needed care.

GLP-1 side effects and safety considerations

For those considering GLP-1 therapy for menopause, it is always a good idea to look at the benefits and potential risks.

Some common side effects of GLP-1 medications include:

• Nausea and vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Loss of appetite
• Headaches
• Infection
• Irritation at the injection site

Patients on GLP-1 therapies can also experience muscle loss or bone density loss with prolonged use, which can compound some of the natural physical changes that accompany menopause.

More severe side effects include pancreatitis, gallbladder issues, and thyroid cancer. The best way to understand the risks of GLP-1s and menopause is to speak with a care provider about health concerns, medical history, and overall goals.

For those who are postmenopausal and exploring GLP-1s, talk to a clinician about safe, personalized dosing or GLP-1 microdosing options.

GLP-1 isn’t a magic fix. Lifestyle still matters.

For anyone interested in GLP-1 therapies for menopause weight loss, it’s important to remember that the medications are not a magic fix. They should be approached with caution and care (and always with the advice of your healthcare provider).

To get the best outcomes from GLP-1 medications, it’s best to combine treatment with:

• A Mediterranean-style diet, which emphasizes eating veggies, fruits, whole grains, and healthy fats.
• Consistent sleep, which helps manage depression and mood changes, as well as hormonal fluctuations that lead to fatigue.
• Exercise for menopausal health to improve cardiovascular health, regulate blood sugar, and increase bone density.

For anyone seeking treatment for weight loss during the menopausal transition, the goal should not be quick weight loss, but rather a holistic, evidence-based approach that supports a person’s individualized needs.

FAQs

Who should consider GLP-1 therapy during menopause?

The ideal candidates for GLP-1 therapy during menopause are those with obesity, insulin resistance, or persistent weight gain despite healthy habits. Most doctors will recommend that candidates try other weight management approaches first before prescribing GLP-1 therapy.

How frequently should I be taking GLP-1 medication?

Are GLP-1s still effective during menopause?

Studies have shown that GLP-1s are equally effective for weight loss regardless of reproductive stage, with similar outcomes among post-menopausal and pre-menopausal women. For those in perimenopause, undergoing GLP-1 therapy can help them manage health concerns at a younger age before they develop into more serious problems during postmenopause.

Are GLP-1s a good first step for menopause weight loss?

Most doctors recommend that candidates have already tried other weight management approaches, including dietary changes and increased physical activity. Before getting started, patients will need to undergo baseline testing and approach treatment under clinical supervision.

Is it normal for midlife women to gain weight during menopause?

Midlife women gain an average of 1.5 pounds per year. While this is a normal part of aging, weight gain during menopause can negatively affect quality of life by contributing to insulin resistance, trouble sleeping, dangerous fat accumulation, and mood changes.

Can GLP-1s be used with menopause hormone replacement therapy?

Yes! In fact, studies have found that combining HRT and GLP-1s results in 35% more weight loss.

For those going through the menopausal transition, hormonal health and weight management often go hand-in-hand. Finding the right balance of treatment through GLP-1s and HRT can improve metabolic resilience and enhance overall quality of life.

What is menopause belly?

Menopause belly usually refers to the accumulation of visceral fat due to the decline of estrogen production during menopause. Visceral fat is normal and something everyone has, which acts as a layer of protection around the organs. However, too much visceral fat can lead to a higher risk of cardiovascular disease. So while weight gain during menopause is completely normal, it’s important to exercise and maintain a healthy diet to manage dangerous visceral fat accumulation.